Helena R.
Moreira
ab,
Rosanne M.
Raftery
cde,
Lucília P.
da Silva
ab,
Mariana T.
Cerqueira
ab,
Rui L.
Reis
ab,
Alexandra P.
Marques
ab and
Fergal J.
O'Brien
*cde
a3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, Avepark, Barco, 4805-017 Guimarães, Portugal
bICVS/3B's – PT Government Associate Laboratory, Braga/Guimarães 4805-017, Portugal
cTissue Engineering Research Group, Dept. of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland. E-mail: fjobrien@rcsi.ie
dTrinity Centre for Biomedical Engineering, Trinity College Dublin (TCD), Dublin, Ireland
eAdvanced Materials and Bioengineering Research (AMBER) Centre, RCSI & TCD, Dublin, Ireland
First published on 29th January 2021
Correction for ‘In vitro vascularization of tissue engineered constructs by non-viral delivery of pro-angiogenic genes’ by Helena R. Moreira et al., Biomater. Sci., 2021, DOI: 10.1039/d0bm01560a.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |